B-Vaxx was mentioned in the Pharma Letter as one of the VAX in trials. But not in the 4C, maybe because it is financed by US comps/government Uni Grants.
Anyway, focus is on Her, PD1 and CF33 which should catapult IMU into a recognized pharma orbit.
GLTA
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 1177 | 1 |
View Market Depth
| Last trade - 10.16am 14/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable